Business Wire

Kinaxis Accelerates Agentic Era for Supply Chain Orchestration with the Launch of Maestro Agents

17.10.2025 13:00:00 CEST | Business Wire | Press release

Share

AI agents that plan with you, not just for you, empower the customer journey to a next generation of the adaptive supply chain

Kinaxis® Inc. (TSX: KXS), a global leader in supply chain orchestration, today announced Maestro Agents, marking the next milestone in AI-enabled decision intelligence for supply chains. Now available to Kinaxis customers and embedded natively in Kinaxis Maestro®, these AI-powered context aware digital co-workers help planners move faster from issue to action, turning disruption into opportunity, and strengthening the resilience of the supply chains that power the global economy.

“Kinaxis agents are already helping our planning team collaborate more effectively with customers and contract manufacturers,” said John Finnigan, Senior Director, Advanced Planning at Jabil. “With human-in-the-loop safeguards, we’re reaching decisions faster today and see strong potential to build a more resilient and networked supply chain.”

Maestro Agents advance the customer journey from conversational AI to decision-based agentic supply chain orchestration. Unlike generic AI assistants that sit outside the process, Maestro Agents are embedded in live planning environments where they understand context, constraints, and trade-offs to plan with you, not for you. With Maestro Agents now live, Kinaxis will continue to expand the Maestro ecosystem with Maestro Agent Studio (now in limited availability) and the arrival of an agent marketplace in 2026, guiding customers through a phased path to realize the full potential of AI-driven orchestration.

“Today’s supply chains operate within an environment of constant volatility. Resilience and adaptability are no longer aspirational - they are mission-critical,” said Andrew Bell, Chief Product Officer at Kinaxis. “Maestro Agents bring explainable AI into the moments that matter for supply chain leaders and practitioners. As our customers continue to coordinate across processes and grow an ecosystem of Kinaxis and partner-built agents, now they can unlock new levels of speed, resilience, and adaptability.”

Proven Value in Real-World Supply Chains

Early adopters describe Maestro Agents as game-changing by cutting hours of manual work and giving planners confidence to act faster with AI that understands their world.

“Flexibility and guardrails are essential if companies are going to trust and scale AI,” said Eric Thompson, Research Director, IDC. “With Maestro Agents, Kinaxis is showing what practical, explainable AI looks like in enterprise operations by embedding agentic capabilities directly into live planning environments so organizations can test, learn, and grow safely and effectively.”

Built to bring decision intelligence into the moment work happens, Maestro Agents turn analysis into action right inside the planning environment. For supply chain planners, they can now rely on agents to:

  • Bring AI into daily work by analyzing live data, flagging issues, and recommending next-best actions directly within Maestro, helping planners move from problem to decision in seconds.
  • Synthesize and unpack real-world constraints by factoring in supplier capacity, inventory levels, production schedules, and customer priorities to deliver recommendations that are achievable and aligned with business goals.
  • Make AI explainable and trustworthy with human-in-the-loop guardrails and clear reasoning that show why each action is recommended.
  • Free up time for higher-value work by automating reporting and routine analysis, enabling planners to focus on strategic decisions that improve performance and resilience and transforming how planners respond to disruption and make decisions in real time.

Customers are already leveraging the robust capabilities of Maestro Agents, and several enterprise organizations have proven how investments in early innovation are delivering significant real-world value within their supply chain environments:

  • A top-10 global pharmaceutical company boosted planner productivity by up to 10×, cutting the steps to identify inventory risks from 40 clicks to just 4 and surfacing insights in seconds instead of minutes or hours, driving significant efficiency gains across its planning process.
  • One of the world’s largest electronics manufacturers streamlined its reporting processes, cutting manual effort and empowering planners to save over 30 hours per month. With this time back, they were able to focus on higher-value initiatives that improved on-time delivery and elevated customer satisfaction.

These innovations represent the next step toward a connected, adaptive future where AI and human expertise orchestrate the world’s supply chains together.

To learn more about how Maestro Agents can accelerate your supply chain, visit kinaxis.com/aiagents.

About Kinaxis

Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.

Forward-Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities laws, including statements about future product capabilities, planned launches, anticipated benefits, and the expected performance or impact of Kinaxis Maestro Agents. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties are described in Kinaxis’ most recent Annual Information Form and other filings with Canadian securities regulators. Kinaxis disclaims any obligation to update or revise these statements, except as required by law.

Source: Kinaxis Inc

View source version on businesswire.com: https://www.businesswire.com/news/home/20251017746583/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Imagine Dragons to Perform at Abu Dhabi Grand Prix21.5.2026 17:51:00 CEST | Press release

Ethara, organiser of the Formula 1 Etihad Airways Abu Dhabi Grand Prix, have announced that one of the world’s biggest bands, Imagine Dragons, will headline the Saturday After-Race Concerts at the F1 Season Finale in Abu Dhabi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521214839/en/ Imagine Dragons to perform at Formula 1 Etihad Airways Abu Dhabi Grand Prix (Photo: AETOSWire) The announcement is another landmark moment for the Abu Dhabi Grand Prix, whose thrilling Yasalam presented by e& fan entertainment offering has become synonymous with the F1 Championship finale in Abu Dhabi and is recognised as one of the most compelling sports and entertainment crossovers globally. The global chart-toppers join Lewis Capaldi and Zara Larsson, who are set to kick off a blockbuster line-up of performances on Yas Island on Thursday, 3 December, with more major international artists to be revealed. With their popular top hits, Ima

Carnegie Mellon University and Cleveland Clinic Develop AI System to Interpret Cardiac MRI Scans with Enhanced Accuracy21.5.2026 14:05:00 CEST | Press release

Trained on more than 13,000 patient studies, novel system significantly outperforms existing models by up to 35% A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521762286/en/ A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s Cardiovascular Innovation Research Center, has developed an artificial intelligence (AI) system capable of interpreting some of the most complex heart scans in medicine, cardiac magnetic resonance imaging (MRI), without the need for manually labeled training data. The novel system, called CMR-CLIP, is d

Otovo Hits 30,000 Customers in Under a Year, Tackling the Growing ‘Solar Service Crisis’21.5.2026 14:00:00 CEST | Press release

A growing wave of unsupported solar systems and rising electricity prices are creating strong demand for Otovo’s energy service platform Otovo ASA (“Otovo”), a leading global energy service provider for residential and commercial customers, today announced it has reached 30,000 customers across the U.S. and Europe. A total of 20,000 customers have enrolled in Otovo Care, the Company’s membership-based home and commercial energy service, which is powered by Otovo’s industry-leading AI platform, Endurance™. “Reaching 30,000 customers in less than year is proof positive that home and business owners value their power systems,” said William J. (John) Berger, CEO of Otovo. “The ‘solar service crisis’ that is leaving millions of orphaned energy systems without support is driving strong interest in our Otovo Care membership program. Every day your home or commercial power system is not working, you are throwing money away. Otovo’s rapid response service platform keeps you up and running, ensu

The Live Moment Effect: Genius Sports and MediaScience Study Finds Specific Moments in Live Sports Can Double Unaided Brand Recall21.5.2026 14:00:00 CEST | Press release

New research shows that brands aligned with emotionally heightened moments in live sports can improve ad effectiveness Genius Sports Limited (NYSE: GENI), a global leader in real-time sports data, today released new biometric research conducted with MediaScience showing that ads delivered immediately after emotionally heightened moments in live sports can double unaided brand recall. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521475265/en/ The Live Moment Effect report from Genius Sports and MediaScience. The study, The Live Moment Effect, finds that advertising effectiveness is significantly influenced by a viewer’s emotional state immediately before an ad is shown. In controlled biometric testing, ads shown after high-intensity sporting moments, such as near-scoring plays or crucial momentum shifts, delivered approximately double the unaided brand recall of baseline conditions. The Moment Before the Ad Matters The r

Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer21.5.2026 14:00:00 CEST | Press release

Precemtabart tocentecan (Precem-TcT) is investigated as a potential first-in-class anti-CEACAM5 ADC, for the treatment of metastatic CRC (mCRC) CEACAM5 is overexpressed in the majority of colorectal tumors (~90%), and requires no patient selection Significant unmet need remains for clinically meaningful innovation in colorectal cancer (CRC), the second leading cause of cancer death worldwide Not intended for Canada-, UK- or US-based media Merck, a leading science and technology company, today announced that the first patient has been dosed in the Phase 3 PROCEADE®-CRC-03 trial (NCT07549412). The study is evaluating precemtabart tocentecan (Precem‑TcT), a potential first‑in‑class investigational anti‑CEACAM5 antibody‑drug conjugate (ADC), for the treatment of metastatic colorectal cancer (mCRC). “Leveraging our novel payload‑linker technology, Precem‑TcT is the first CEACAM5‑targeted ADC in clinical studies with an exatecan payload, rationally designed for stability and enhanced cancer

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye